Abstract
Purpose
To evaluate the stability of intraocular lenses (IOLs) according to the haptic design in combined surgery (phacoemulsification, intraocular lens insertion, and vitrectomy) by comparing early IOP elevation and the accuracy of IOL power.
Methods
A retrospective study was conducted for 85 eyes of 85 patients who had undergone combined surgery. IOP elevation one week postoperatively and the difference between target refraction and postoperative refraction after two months were evaluated in all patients. All eyes were allocated to either a 2-haptic IOL group or a 4-haptic IOL group, and then each group was divided into three subgroups: gas-filled, silicone oil-filled, or balanced salt solution-filled.
Results
In the balanced salt solution-filled group, the early IOP increase was significantly less in the 4-haptic IOL group than it was in the 2-haptic IOL group (3.24 mmHg vs. 6.15 mm Hg, p=0.025).
The myopic shifts of the 2-haptic IOL group were significantly greater than those of the 4-haptic IOL group for all of the sub-groups (gas subgroup -0.71D vs. -0.31D, p=0.045; balanced salt solution subgroup -0.66D vs. -0.16D, p=0.018).
References
1. Koening SB, Han DP, Mieler WF, et al. Combined phacoemulsification and pars plana vitrectomy. Arch Ophthalmol. 1990; 108:362–4.
2. Benson WE, Brown GC, Tasman W, et al. Extracapsular cataract extraction, posterior chamber lens insertion, and pars plana vitrectomy in one operation. Ophthalmology. 1990; 97:918–21.
3. Smiddy WE, Stark WJ, Michels RG, et al. Cataract extraction after vitrectomy. Ophthalmology. 1987; 94:483–7.
4. Hutton WL, Pesicka GA, Fuller DG. Cataract extraction in the diabetic eye after vitrectomy. Am J Ophthalmol. 1987; 104:1–4.
5. Lahey JM, Francis RR, Kearney JJ. Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases. Ophthalmology. 2003; 110:1335–9.
6. Koenig SB, Mieler WF, Han DP, et al. Combined phacoemulsification, pars plana vitrectomy, and posterior chamber intraocular lens insertion. Arch Ophthalmol. 1992; 110:1101–4.
7. Hurley C, Barry P. Combined endocapsular phacoemulsification, pars plana vitrectomy, and intraocular lens implantation. J Cataract Refract Surg. 1996; 22:462–6.
8. Blankenship GW, Flynn HW, Kokame GT. Posterior chamber intraocular lens insertion during pars plana lensectomy and vitrectomy for complications of proliferative diabetic retinopathy. Am J Ophthalmol. 1989; 108:1–5.
9. Hwang JJ, Kim YY, Huh K. Risk factors of intraocular pressure evaluation after pars plana vitrectomy. J Korean Ophthalmol Soc. 2000; 41:945–50.
10. Suzuki Y, Sakuraba T, Mizutani H, et al. Postoperative refractive error after simultaneous vitrectomy and cataract surgery. Ophthamic Surg Lasers. 2000; 31:271–5.
11. Jeoung JW, Chung H, Yu HG. Factors influencing refractive outcomes after combined phacoemulsification and pars plana vitrectomy. J Cataract Refract Surg. 2007; 33:108–14.
12. Sun HJ, Choi KS. Improving intraocular lens power prediction in combined phacoemulsification and vitrectomy in eyes with macular oedema. Acta Ophthalmol. 2009. Nov; Epub.
13. Ehmann D, García R. Investigating a possible cause of myopic shift after combined cataract extraction, intraocular lens implantation, and vitrectomy for treatment of macular hole. Can J Ophthalmol. 2009; 44:594–7.
14. Han DP, Lewis H, Lambrow FH, et al. Mechanisms of intraocular pressure elevation after pars plana vitrectomy. Ophthalmology. 1989; 96:1357–62.
15. Chang S, Coleman DJ, Lincoff H, et al. Perfluoropropane gas in the management of proliferative vitreoretinopathy. Am J Ophthalmol. 1984; 98:180–8.
16. Lincoff H, Coleman J, Kreissig I, et al. The perfluorocarbon gases in the treatment of retinal detachment. Ophthalmology. 1983; 90:546–51.
17. Chang S, Lincoff H, Coleman DJ, et al. Perfluorocarbon gases in vitreous surgery. Ophthalmology. 1985; 92:651–6.
18. Lincoff H, Kreissif I, Brodie S, et al. Expanding gas bubbles for the repair of tears in the posterior pole. Graefes Arch Klin Exp Ophthalmol. 1982; 219:193–7.
19. Peters MA, Abrams GW, Hamilton LH, et al. The nonexpansile, equilibrated concentration of perfluoropropane gas in the eye. Am J Ophthalmol. 1985; 100:831–9.
20. Ni C, Wang WJ, Albert DM, et al. Intravitreous silicone injection. Histopathologic findings in a human eye after 12 years. Arch Ophthalmol. 1983; 101:1399–401.
21. Lee SS, Kim HJ. Clinical Results of Acrysof IOLs and Acryl-C160 IOLs in Complicated Cataracts. J Korean Ophthalmol Soc. 2002; 43:35–41.
22. Lee JY, Joo KM, Kim SH. Late Opacification of Hydrophilic Acrylic Intraocular Lenses. J Korean Ophthalmol Soc. 2002; 43:2419–29.
23. Kim SW, Kim HS, Oh JR, et al. Risk Factors of Posterior Synechia of the Iris after Performing Vitrectomy and Cataract Surgery Simultaneously. J Korean Ophthalmol Soc. 2005; 46:1128–37.
Table 1.
Table 2.
2-haptic IOL group | 4-haptic IOL group | |
---|---|---|
Age (years) | 63.40±10.25 | 66.15±6.17 |
Sex | ||
Male (n) | 22 | 15 |
Female (n) | 24 | 24 |
Systemic disease | ||
Diabetes (n) | 37 | 29 |
Hypertension (n) | 29 | 26 |
Cause (%) | ||
* PDR vitreous hemorrhage | 20 (43.5) | 16 (41.0) |
PDR c † TRD | 8 (17.4) | 9 (23.1) |
‡ BRVO vitreous hemorrhage | 7 (15.2) | 5 (12.8) |
Retinal tear c § RD | 7 (15.2) | 4 (12.3) |
Macular hole | 2 (4.3) | 3 (7.7) |
Macular hemorrhage | 2 (4.3) | 2 (5.1) |
Total | 46 (100) | 39 (100) |
Table 3.
2-haptic IOL (n=46) | 4-haptic IOL (n=39) | § p-value | |
---|---|---|---|
Preoperative | |||
Axial length (mm) | 23.10±0.98 | 23.45±1.14 | 0.203 |
Anterior chamber depth (mm) | 3.06±0.32 | 3.09±0.43 | 0.368 |
Intraocular pressure (mm Hg) | 11.47±2.94 | 12.55±2.66 | 0.604 |
Material of tamponade | |||
C3F8 gas tamponade (n) | 17 | 12 | |
* IOP increase (mm Hg) | 9.17±10.25 | 9.75±14.82 | 0.512 |
† Myopic shift (Diopter) | -0.71±1.09 | -0.31±0.84 | 0.045 |
Silicone oil tamponade | 10 | 13 | |
* IOP increase (mm Hg) | 11.22±9.74 | 9.34±10.25 | 0.429 |
With removal (n) | 4 | 5 | |
‡ Myopic shift (Diopter) | -0.69±0.81 | -0.87±0.62 | 0.102 |
Balanced salt solution (n) | 19 | 14 | |
* IOP increase (mm Hg) | 6.15±8.13 | 3.24±4.12 | 0.025 |
† Myopic shift (Diopter) | -0.66±1.02 | -0.16±0.70 | 0.018 |
* Difference between maximum value of postoperative IOP within postoperative 1-week and preoperative IOP;
† Difference between post-vitrectomy 2 months spherical equivalent and preoperative target spherical equivalent;